WalletHub released a new analysis ranking America's most overweight cities, based on obesity rates, health consequences and ...
Fatty liver disease, medically called metabolic dysfunction-associated steatotic liver disease (MASLD), affects millions ...
Annual costs related to obesity are estimated at $1.4 trillion in the United States. This financial burden stems from increased demand for chronic disease management, resource reallocation toward ...
Obesity is a major global health issue, increasing the risk of heart disease, diabetes, and high blood pressure. Despite many ...
A new study in The Journal of Immunology reveals how a high-fat diet may impair the immune system's ability to respond to infection by impacting the function of neutrophils, one of the first immune ...
US pharma giants eye India’s obesity crisis with pricey shots, sparking ‘Make in India’ and affordability debates ...
The Danish drugmaker is also testing semaglutide - sold as the diabetes drug Ozempic and the obesity drug Wegovy - in thousands of patients with early-stage Alzheimer's disease, with results ...
The Maryland-based biopharma joins Eli Lilly and Novo Nordisk in trialing a GLP-1 agonist for alcohol- and liver-related ...
Experts advocate maintaining BMI 25 standard for obesity at Korean health conference Health experts call for adherence to BMI ...